US 11254913
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted A61KA61K2039/55533A61K2239/57
Quick answer
US patent 11254913 (Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy) held by Iovance Biotherapeutics, Inc. expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Iovance Biotherapeutics, Inc.
- Grant date
- Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/55533, A61K2239/57, A61K31/675, A61K31/7076